BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 11, 2005
View Archived Issues
Angiotensin II type 1 receptor antagonism attenuates experimental colitis
Read More
UPF-680's positive effects on biliary function
Read More
New study raises the red flag for PDE4 inhibitors
Read More
FDA accepts for review CIP-Isotretinoin NDA
Read More
Kemia begins phase I trials with novel kinase inhibitor for inflammatory indications
Read More
Viventia Biotech reports update on VB4-845 for bladder cancer
Read More
Enzo reports promising preclinical results of potential bone growth compound
Read More
Promising preclinical data reported for IBD compound at Advitech
Read More
Abmaxis and MaimoniDex establish alliance for RA drug discovery
Read More
ADX-47273 - a novel mGluR5-positive allosteric modulator
Read More
Treg cells exposed to JJ-316 protect against EAE
Read More
hVps34, a class 3 PI3K, identified as a potential antiobesity target
Read More
SGN-30's growth arrest and synergistic effects with chemotherapeutics for HD
Read More
Testosterone MDTS improves libido of premenopausal women with low testosterone levels
Read More
Anidulafungin reported well tolerated in patients with invasive candidiasis/candidemia
Read More
Update on the antibacterial effects and the pharmacokinetics of ceftobiprole
Read More
Ambien CR available in U.S. for insomnia
Read More
New preclinical data on the effects of tacrolimus in skin disorders
Read More
Critical Therapeutics plans Zyflo launch
Read More
Novel coagulation factor Xa inhibitors emerge from Boehringer Ingelheim R&D
Read More
Therapeutic agents for osteoporosis reported in recent patent literature
Read More
Vitespen reported to improve survival of patients with metastatic melanoma
Read More
Novel therapeutic agents for HIV infection disclosed
Read More
Novel immunomodulatory agents claimed
Read More
New potential analgesic agents in early development
Read More
New data on the efficacy of imiquimod in lentigo maligna
Read More